Results 251 to 260 of about 91,122 (346)
Correction to "Putaminal hypermetabolism identifies Lewy body co-pathology in Alzheimer's disease". [PDF]
europepmc +1 more source
Uncovering α-synuclein and tau burden in Alzheimer's and Lewy body diseases. [PDF]
Quintin S +4 more
europepmc +1 more source
Ginsenoside Rg1 (Rg1) from Panax ginseng shows multifunctional health effects. Although oral bioavailability is low and blood–brain barrier (BBB) penetration is limited, delivery systems such as liposomes and nanoparticles may improve exposure. Rg1 reduces inflammation/oxidative stress by inhibiting nuclear factor‐κB (NF‐κB) signaling and reactive ...
Hernán Cortés +13 more
wiley +1 more source
Recognition memory span in autopsy-confirmed Dementia with Lewy Bodies and Alzheimer's Disease
David P. Salmon +7 more
openalex +2 more sources
Intrinsic capacity in Lewy body dementia: a review. [PDF]
Sanapo F +3 more
europepmc +1 more source
ABSTRACT Objectives Aggressive behaviour and decreased empathy occur in many dementia syndromes. This may be related to lowered overall cognitive functioning which is a common feature of dementia. However, to date, the role of social cognitive impairments such as facial emotion recognition (FER) deficits in dementias other than behavioural variant ...
Aafra T. Ter Horst +2 more
wiley +1 more source
Loxapine for the treatment of psychosis in Lewy body dementia: A case report. [PDF]
Wu L, Jhawar A.
europepmc +1 more source
Neurons, immune cells, and other cellular components within the disease microenvironment (such as stromal cells and tumor cells) constitute a dynamically evolving ecosystem. Neurons directly modulate immune cell activity and inflammatory responses through the release of neurotransmitters (e.g., norepinephrine and CGRP), while also promoting tumor ...
Xin Guo +11 more
wiley +1 more source

